Emricasan (IDN-6556) administered orally for 28 days lowers portal pressure in patients with compensated cirrhosis and severe portal hypertensionGuadalupe Garcia-Tsao,Michael Fuchs,Mitchell L. Shiffman,Jean L. Chan,Mark Morris,Mason Yamashita,Alfred P. Spada,David Hagerty,Jaime BoschHEPATOLOGY(2015)引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要